Novel 4-substituted pyridine derivatives: Practical derivatization and biological profiles of reversible H+/K+-ATPase inhibitors

Bioorganic and Medicinal Chemistry Letters

Volumn 7, Issue 5, 1997, Pages 527-532

  Niiyama, Kenji ^a   Nagase, Toshio ^a   Fukami, Takehiro ^a   Takezawa, Yumi ^a   Takezawa, Hiroshi ^a   Hioki, Yoshio ^a   Takeshita, Hiroshi ^a   Ishikawa, Kiyofumi ^a  

^a BANYU PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 [1 HYDROXY 3 (1 NAPHTHYL) 2 PROPEN 2 YL] 5 METHYL 4 (2,2 DIMETHYLPROPOXY)PYRIDINE; 2 [1 HYDROXY 3 (1 NAPHTHYL) 2 PROPYL] 5 METHYL 4 PHENOXYPYRIDINE; ADENOSINE TRIPHOSPHATASE INHIBITOR; ANTIULCER AGENT; AU 2064; PYRIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ACID SECRETION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG SYNTHESIS; ENZYME INHIBITION; IN VITRO STUDY; INTRAGASTRIC DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MASS SPECTROMETRY; METHODOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PH; RAT; REACTION ANALYSIS; STOMACH; SWINE;

EID: 0031552143     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(97)00056-5     Document Type: Article

References (18)

1. 1. Sachs, G.; Chang, H. H.; Rabon, E.; Shackman, R.; Lewin, M.; Saccomani, G. J. Biol. Chem. 1976, 257, 7690.
2. 2. For example: a) Borg, K. O.; Olbe, L.; Rune S. J.; Walan, A. Scand. J. Gastroenterol. 1986, 21 (Suppl. 118), 1;
3. b) Clissold, S. P.; Campoli-Richards, D. M. Drugs 1986, 32, 15.
4. 3. Carlsson, E.; Larsson, H.; Mattsson, H.; Ryberg, B.; Sundell, G. Scand. J. Gastroenterol. 1986, 21 (Suppl. 118), 31.
5. 4. Hakanson, R.; Sunder, F. Trends in Pharmacol. Sci. 1986, 7, 386.
6. 5. Parsons, M. E.; Pope, A. J. Trends in Pharmacol. Sci. 1993, 14, 323.
7. 6. a) Ife, R. J.; Leach, C. A.; Pope, A. J.; Theobald, C. J. BioMed. Chem. Lett. 1995, 5, 543 and references cited therein;
8. b) LaMattina, J. L.; McCarthy, P. A.; Reiter, L. A.; Holt, W. F.; Yen, L-A. J. Med. Chem. 1990, 33, 543;
9. c) Kaminski, J. J.; Puchalski, C.; Solomon, D. M.; Rizvi, R. K.; Conn, D. J.; Elliott, A. J.; Lovey, R. G.; Guzik, H.; Chiu, P. J. S.; Long, J. F.; McPhail, A. T. ibid. 1989, 32, 1686 and references cited therein.
10. 7. The in vitro activities and antisecretory properties of AU-2064: Takeshita, H.; Hirayama, Y.; Amano, H.; Hioki, Y.; Takada, J.; Ishikawa, K.; Yano, M. Jpn. J. Pharmacol. 1990, 52 (Suppl. I), 242.
11. 8. The in vitro and in vivo studies on AU-1421, a representative prototype of this series: Hioki, Y.; Takada, J.; Hidaka, Y.; Takeshita, H.; Hosoi, M.; Yano, M. Arch. Int. Pharmacodyn. Ther. 1990, 305, 32.
12. 9. For example, Kubo, K., Oda, K.; Kaneko, T.; Satoh, H.; Nohara, A. Chem. Pharm. Bull. 1990, 38, 2853.
13. 10. a) Barlin, G. B.; Brown, W. V. J. Chem. Soc., (B) 1967, 648;
14. b) Idem. J. Chem. Soc., (B) 1968, 1435.
15. 11. a) Furukawa, N.; Ogawa, S.; Kawai, T.; Oae, S. J. Chem. Soc., Perkin Trans, I 1984, 1839 and references cited therein;
16. b) review for the ipso-substitution of pyridine derivatives: Furukawa, N. J. Synth. Chem. Jpn. 1987, 45, 624.
17. +): Calcd: 470.2185; Found:470.2183.
18. +): Calcd: 346.2277; Found: 364.2268.